nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.0403	0.0403	CcSEcCtD
Frovatriptan—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.033	0.033	CcSEcCtD
Frovatriptan—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.0288	0.0288	CcSEcCtD
Frovatriptan—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0271	0.0271	CcSEcCtD
Frovatriptan—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0271	0.0271	CcSEcCtD
Frovatriptan—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0238	0.0238	CcSEcCtD
Frovatriptan—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0205	0.0205	CcSEcCtD
Frovatriptan—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0203	0.0203	CcSEcCtD
Frovatriptan—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0198	0.0198	CcSEcCtD
Frovatriptan—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.0195	0.0195	CcSEcCtD
Frovatriptan—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.0184	0.0184	CcSEcCtD
Frovatriptan—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0181	0.0181	CcSEcCtD
Frovatriptan—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0175	0.0175	CcSEcCtD
Frovatriptan—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.0172	0.0172	CcSEcCtD
Frovatriptan—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.0159	0.0159	CcSEcCtD
Frovatriptan—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.0157	0.0157	CcSEcCtD
Frovatriptan—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.0146	0.0146	CcSEcCtD
Frovatriptan—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.0144	0.0144	CcSEcCtD
Frovatriptan—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.0139	CcSEcCtD
Frovatriptan—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.0138	0.0138	CcSEcCtD
Frovatriptan—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.0132	0.0132	CcSEcCtD
Frovatriptan—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0129	0.0129	CcSEcCtD
Frovatriptan—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.0128	0.0128	CcSEcCtD
Frovatriptan—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0124	0.0124	CcSEcCtD
Frovatriptan—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0123	CcSEcCtD
Frovatriptan—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.0121	0.0121	CcSEcCtD
Frovatriptan—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.012	CcSEcCtD
Frovatriptan—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0119	CcSEcCtD
Frovatriptan—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0116	CcSEcCtD
Frovatriptan—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.0114	0.0114	CcSEcCtD
Frovatriptan—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.0114	0.0114	CcSEcCtD
Frovatriptan—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.011	0.011	CcSEcCtD
Frovatriptan—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0102	CcSEcCtD
Frovatriptan—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.01	CcSEcCtD
Frovatriptan—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00974	0.00974	CcSEcCtD
Frovatriptan—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00924	0.00924	CcSEcCtD
Frovatriptan—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00889	0.00889	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00879	0.00879	CcSEcCtD
Frovatriptan—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00874	0.00874	CcSEcCtD
Frovatriptan—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00869	0.00869	CcSEcCtD
Frovatriptan—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00867	0.00867	CcSEcCtD
Frovatriptan—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00841	0.00841	CcSEcCtD
Frovatriptan—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00837	0.00837	CcSEcCtD
Frovatriptan—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00805	0.00805	CcSEcCtD
Frovatriptan—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00803	0.00803	CcSEcCtD
Frovatriptan—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00801	0.00801	CcSEcCtD
Frovatriptan—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00797	0.00797	CcSEcCtD
Frovatriptan—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00795	0.00795	CcSEcCtD
Frovatriptan—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00791	0.00791	CcSEcCtD
Frovatriptan—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00785	0.00785	CcSEcCtD
Frovatriptan—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00771	0.00771	CcSEcCtD
Frovatriptan—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00746	0.00746	CcSEcCtD
Frovatriptan—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00743	0.00743	CcSEcCtD
Frovatriptan—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00718	0.00718	CcSEcCtD
Frovatriptan—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00715	0.00715	CcSEcCtD
Frovatriptan—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00701	0.00701	CcSEcCtD
Frovatriptan—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00697	0.00697	CcSEcCtD
Frovatriptan—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00687	0.00687	CcSEcCtD
Frovatriptan—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00684	0.00684	CcSEcCtD
Frovatriptan—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00682	0.00682	CcSEcCtD
Frovatriptan—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00677	0.00677	CcSEcCtD
Frovatriptan—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.0067	0.0067	CcSEcCtD
Frovatriptan—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00653	0.00653	CcSEcCtD
Frovatriptan—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00647	0.00647	CcSEcCtD
Frovatriptan—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.0064	0.0064	CcSEcCtD
Frovatriptan—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00628	0.00628	CcSEcCtD
Frovatriptan—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00626	0.00626	CcSEcCtD
Frovatriptan—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00604	0.00604	CcSEcCtD
Frovatriptan—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00593	0.00593	CcSEcCtD
Frovatriptan—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00593	0.00593	CcSEcCtD
Frovatriptan—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00593	0.00593	CcSEcCtD
Frovatriptan—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00591	0.00591	CcSEcCtD
Frovatriptan—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00586	0.00586	CcSEcCtD
Frovatriptan—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.0058	0.0058	CcSEcCtD
Frovatriptan—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00573	0.00573	CcSEcCtD
Frovatriptan—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00569	0.00569	CcSEcCtD
Frovatriptan—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.0055	CcSEcCtD
Frovatriptan—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00542	0.00542	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00518	0.00518	CcSEcCtD
Frovatriptan—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.00514	CcSEcCtD
Frovatriptan—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00511	0.00511	CcSEcCtD
Frovatriptan—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00507	0.00507	CcSEcCtD
Frovatriptan—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00506	0.00506	CcSEcCtD
Frovatriptan—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00501	0.00501	CcSEcCtD
Frovatriptan—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.00494	CcSEcCtD
Frovatriptan—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0049	0.0049	CcSEcCtD
Frovatriptan—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00486	0.00486	CcSEcCtD
Frovatriptan—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00486	0.00486	CcSEcCtD
Frovatriptan—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.00469	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00465	0.00465	CcSEcCtD
Frovatriptan—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.0045	CcSEcCtD
Frovatriptan—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.0045	CcSEcCtD
Frovatriptan—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00419	0.00419	CcSEcCtD
Frovatriptan—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00408	0.00408	CcSEcCtD
Frovatriptan—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.00402	CcSEcCtD
Frovatriptan—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00389	0.00389	CcSEcCtD
Frovatriptan—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00376	0.00376	CcSEcCtD
Frovatriptan—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00362	0.00362	CcSEcCtD
Frovatriptan—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00356	CcSEcCtD
Frovatriptan—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.00338	CcSEcCtD
